Navigation Links
NexBio to Present at 2009 Biotech Showcase
Date:1/13/2009

SAN DIEGO, Jan. 13 /PRNewswire/ -- NexBio, a privately held development-stage biopharmaceutical company located in San Diego, announced today that David Wurtman, MD, MBA, Vice President of Corporate Development, will present a corporate overview at the upcoming 2009 Biotech Showcase in San Francisco, CA, on January 14, 2009 at 2:15pm. NexBio's corporate mission is to save lives and to improve the quality of life by creating and commercializing novel, broad-spectrum biopharmaceuticals to prevent and treat current and emerging life-threatening diseases.

NexBio's pipeline consists of two novel biopharmaceuticals invented internally, DAS181 (Fludase(R)), in clinical development, and Viradin(TM), at lead optimization stage, as well as TOSAP(TM), an important new microparticle formulation technology. Corporate funding to date has been entirely non-dilutive, consisting of five grants totaling $13M, together with a BAA Contract for $49.8M to support Fludase(R) development, all from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

Fludase(R) is a broad-spectrum drug candidate for the prophylaxis and treatment of respiratory infections by all variations of influenza virus, including the types of virus that may cause a potential influenza pandemic. In addition, Fludase(R) has the potential for prophylaxis and treatment of seasonal influenza-like illness due to multiple respiratory viruses, including parainfluenza virus, which may cause a serious respiratory illness similar to influenza and for which there is no approved vaccine or therapeutic. Fludase(R) is a recombinant fusion protein that inactivates viral receptors on the cells of the human respiratory tract, thereby preventing influenza and parainfluenza viruses both from infecting the human body and from amplifying in already-infected individuals. Fludase(R) effectively inhibits numerous strains of influenza and parainfluen
'/>"/>

SOURCE NexBio
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Keryx Biopharmaceuticals to Present at the J.P. Morgan 27th Annual Healthcare Conference
2. Biology in Pico-Liter Droplets is Focus of Presentation at LabAutomation 2009
3. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JPMorgan Conference
4. ImmunoVaccine Technologies Presents at OneMed Place Finance Forum
5. Schering-Plough to Webcast Presentation at 27th Annual J.P. Morgan Healthcare Conference
6. Endo Pharmaceuticals to Present at the J.P. Morgan 27th Annual Healthcare Conference
7. InteKrin Therapeutics to Present at the 27th Annual JP Morgan Healthcare Conference on Tuesday, January 13
8. Martek to Present at 11th Annual ICR XChange
9. Ikaria(R) to Present at 27th Annual JPMorgan Healthcare Conference
10. BioCryst to Present at the J.P. Morgan 27th Annual Healthcare Conference
11. ARCA biopharma to Present at 27th Annual JPMorgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... CITY, Calif. , March 4, 2015 /PRNewswire/ ... ), a specialty pharmaceutical company focused on the ... treatment of acute and breakthrough pain, today announced ... 2014 financial results after market close on Monday, ... investment-community conference call at 4:30 p.m. Eastern Time ...
(Date:3/4/2015)... San Jose, California (PRWEB) March 04, 2015 ... Chain Reaction (PCR) represents one of the fastest growing ... among cell biologists in subcellular visualization is driving growth ... The need for deeper understanding of gene expressions will ... reagents market. Expanding applications in fields ranging from pharma, ...
(Date:3/4/2015)... ANDOVER, Massachusetts , March 4, 2015 /PRNewswire/ ... Unternehmen präsentiert innovative Entwicklungen für Diagnostik und Therapie, ... Gesundheitsversorgung   Royal Philips ... am Europäischen Röntgenkongress 2015 (ECR) bekannt, ... stattfindet. An den Ständen Nr. ...
(Date:3/3/2015)... 3, 2015 NASA astronaut Scott Kelly , ... to spend a year living and working on the International ... 5:30 to 7 a.m. EDT Monday, March 9. ... he completes the final weeks of his training. The interviews ... NASA Television highlighting his mission training and previous spaceflights. ...
Breaking Biology Technology:AcelRx Pharmaceuticals to Hold Annual 2014 Financial Results Conference Call and Webcast on Monday, March 9th, 2015 2AcelRx Pharmaceuticals to Hold Annual 2014 Financial Results Conference Call and Webcast on Monday, March 9th, 2015 3Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 2Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 3Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 4Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 2Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 3Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 4Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 5Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 6NASA Astronaut Scott Kelly Available for Interviews before One-Year Space Station Mission 2
... , NEW YORK , ... (OTC Bulletin Board: ILNS), a biopharmaceutical company focused ... ("AD"), announced today that several of its significant shareholders ... interim funding to the Company and assist the Company ...
... SILVER SPRING, Md. , and INDIANAPOLIS , Feb. ... United Therapeutics Corporation (Nasdaq: UTHR ), announced today that ... to pursue development of ImmuneWorks, lead compound, IW001, a purified ... Idiopathic Pulmonary Fibrosis (IPF) and Primary Graft Dysfunction (PGD) in ...
... , , NEW YORK , ... Vice President James C. Borel said he expects the ... in 2010 and increase pre-tax operating income margin across the seed, ... on customers and investing to meet their needs is paying off," ...
Cached Biology Technology:Intellect Neurosciences, Inc. Announces Preliminary Agreement with Significant Shareholders to Provide Interim Funding and Assist the Company in Efforts to Secure Additional Financing 2Intellect Neurosciences, Inc. Announces Preliminary Agreement with Significant Shareholders to Provide Interim Funding and Assist the Company in Efforts to Secure Additional Financing 3Intellect Neurosciences, Inc. Announces Preliminary Agreement with Significant Shareholders to Provide Interim Funding and Assist the Company in Efforts to Secure Additional Financing 4Lung Rx and ImmuneWorks Announce Collaboration in Idiopathic Pulmonary Fibrosis and Primary Graft Dysfunction 2Lung Rx and ImmuneWorks Announce Collaboration in Idiopathic Pulmonary Fibrosis and Primary Graft Dysfunction 3DuPont Expects Strong 2010 Agriculture & Nutrition Sales Growth, Margin Expansion 2DuPont Expects Strong 2010 Agriculture & Nutrition Sales Growth, Margin Expansion 3DuPont Expects Strong 2010 Agriculture & Nutrition Sales Growth, Margin Expansion 4DuPont Expects Strong 2010 Agriculture & Nutrition Sales Growth, Margin Expansion 5
(Date:3/2/2015)... March 2, 2015   Neurotechnology , a provider ... the SentiGaze Software Development Kit (SDK). The ... that use off-the-shelf webcams to track eye movements and ... a monitor. Heatmaps can be used for applications such ... online advertising. The SDK can also be used to ...
(Date:2/24/2015)... 2015 Research and Markets ( ... "Global 2D Gesture Recognition Market 2015-2019" ... analysts forecast the Global 2D Gesture Recognition market ... the period 2014-2019 The increased demand ... one of the major trends in the market. ...
(Date:2/13/2015)... ACT Genomics Co., Ltd., a cancer ... cancer genomic information into precision diagnosis and personalized ... US$ 8 million in the its first private funding ... Taiwan , ACT Genomics has developed comprehensive ... to implement next generation sequencing (NGS) and multiplex ...
Breaking Biology News(10 mins):Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 2Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 3Global 2D Gesture Recognition Market 2015-2019 with Cognitec Systems, CogniVue, eyeSight Mobile Technologies & PointGrab Dominating 2ACT Genomics Raises $8 Million in its First Private Funding Round 2
... million grant from the National Science Foundation to lead ... agricultural crop plants able to withstand drought conditions. The ... plant ( Brassica napus ). Canola is an important ... production. June Kwak, associate professor of cell biology and ...
... AVIV, Israel - European business leaders and high-level representatives ... entrepreneurs and industries, will gather in Tel Aviv during ... the first event in Israel under the Israeli EUREKA ... of the EUREKA Network and will provide European industries ...
... HILL, Mass. (10/25/2010) The development and first use ... mosquito have established 400,000 genetic markers capable of revealing ... insecticides and other preventive measures, according to findings published ... . The SNP array,s snapshot of the Anopheles ...
Cached Biology News:UMD to lead $5 million NSF-funded research partnership to develop drought-tolerant canola crops 2UMD to lead $5 million NSF-funded research partnership to develop drought-tolerant canola crops 3Israeli Minister of Industry and Trade to address European R&D leaders in Tel Aviv 2Genetic markers offer new clues about how malaria mosquitoes evade eradication 2Genetic markers offer new clues about how malaria mosquitoes evade eradication 3
... of long double stranded RNA (dsRNA) has ... a diverse group of organisms as well ... leads to the inhibition of protein expression ... target messenger RNA (mRNA). Attempts to induce ...
... in an easy-to-use benchtop package. Our ... (ESI-oa-TOF) concentrates the performance of a ... fits on your bench. The microTOFLC ... FWHM and mass accuracy of better ...
... Definitive Performance The TSQ Quantum ... excellence in bioanalytical and environmental analysis. ... ESI and APCI probes, a titanium skimmer ... increased robustness and sensitivity. Its redesigned ...
... uptake of long double stranded RNA (dsRNA) ... in a diverse group of organisms as ... interference leads to the inhibition of protein ... the target messenger RNA (mRNA). Attempts to ...
Biology Products: